Miraculous Medicines

teleport me to a random drug
Minted: - / 5000

3699 Tavilermide
9e28e310bbc7ded58006e56f7d44e9358de02012e168de9d958274436fd15810

This DRUG has not been minted yet.
Mint it now with MetaMask!

Send:
ETH
and donate to medical research.
Note: transaction fees shown in metamask are an approximation and are likely to be smaller.

Tavilermide (INN) (developmental code name MIM-D3) is a selective, cyclic peptide partial agonist of TrkA. (this class of drugs are sometimes known as nerve growth factor (NGF) mimetics) Tavilermide was first synthesized by Burgess and co-workers at Texas A&M University with the intention of producing TrkA agonists. It is under development by Mimetogen Pharmaceuticals as an ophthalmic (eye drop) solution for the treatment of dry eyes, and is in phase III clinical trials for this indication. Tavilermide is currently being evaluated in two multi-center phase III clinical studies in the United States for the treatment of dry eye disease.1 Tavilermide is also in phase I clinical trials for the treatment of glaucoma; studies are ongoing.

From Wikipedia, the free encyclopedia. License: CC BY-SA.